Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001472850-25-000004
Filing Date
2025-02-14
Accepted
2025-02-14 17:56:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12497
2 permex99.pdf EX-99.1 96972
  Complete submission text file 0001472850-25-000004.txt   147803
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Subject) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G | Act: 34 | File No.: 005-86354 | Film No.: 25631483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3401 ARMSTRONG AVE DALLAS TX 75205
Business Address 3401 ARMSTRONG AVE DALLAS TX 75205 212.257.6066
Permian Investment Partners, LP (Filed by) CIK: 0001472850 (see all company filings)

EIN.: 262071119 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G